Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter.
Xia ShaoPengcheng XuLili JiBoting WuYanxia ZhanXibing ZhuangYang OuFanli HuaLihua SunFeng LiXiangdong WangHao ChenYunfeng ChengPublished in: Clinical and translational medicine (2023)
Low-dose DAC promoted M2 macrophage polarization due to the demethylation within the promoter of PPARγ, thus enhanced the KLF4 binding affinity in ITP.